Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 8,021.13 174.29 -47.18 -1,398.08 -31.28 0.00 5.2815 -0.58 -0.2579 -25.1259 -0.11 -0.11 7.8459 - -
Maximum - - - - - - 133,371.00 2,687.00 1,099.00 12,431.00 1,058.00 0.01 701.8537 4.26 3.0051 85.3485 0.15 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -16.7400 -1,444.7800 -1.56 -12.64 0.0007 - -
Intellia Therapeutics, Inc. NTLA 16.73 0.73 4.56% 2,370 vs. 1,884 1,699.00 28.00 -107.00 -123.00 -1,765.00 -1.1200 -6.0491 0.0000 0.9132 -3.7130 -0.1037 -0.0853 8.4537 101.00
United Therapeutics Corporation UTHR 410.00 7.43 1.85% 498 vs. 394 18,304.00 677.00 306.00 338.00 6,333.00 6.5200 8.7477 0.0000 0.8924 0.4524 0.0574 0.0472 3.5035 44.00
CRISPR Therapeutics AG CRSP 51.62 -0.26 -0.50% 1,291 vs. 1,115 4,405.00 0.00 -116.00 109.00 -1,116.00 -1.4300 -11.9580 0.0000 -101.7758 -231.3313 -0.0559 -0.0478 17.7168 85.00
Incyte Corporation INCY 83.38 1.04 1.26% 2,504 vs. 1,839 16,063.00 880.00 169.00 209.00 329.00 0.7600 18.7480 0.0000 0.9308 0.1925 0.0314 0.0238 3.2913 192.00
Alnylam Pharmaceuticals, Inc. ALNY 277.43 5.21 1.91% 848 vs. 805 35,783.00 494.00 -65.00 -94.00 -7,075.00 -0.5200 -73.3326 0.0000 0.8665 -0.1334 0.3007 -0.0172 2.8593 128.00
ImmunoGen, Inc. IMGN 31.23 0.01 0.02% 19,311 vs. 8,287 8,725.00 113.00 30.00 1.00 -1,708.00 0.1000 37.1085 0.0000 0.9810 0.2711 0.0548 0.0374 5.4673 279.00
Apellis Pharmaceuticals, Inc. APLS 29.98 1.24 4.31% 4,070 vs. 2,360 3,650.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 121.00
Madrigal Pharmaceuticals, Inc. MDGL 350.70 -4.15 -1.17% 454 vs. 346 7,648.00 0.00 -147.00 -149.00 -1,483.00 -7.3800 -8.6674 0.0000 0.0000 0.0000 -0.1734 -0.1363 9.2623 21.00
Regeneron Pharmaceuticals, Inc. REGN 828.42 3.94 0.48% 556 vs. 639 89,529.00 3,145.00 722.00 1,350.00 27,982.00 6.7000 36.1813 0.0000 0.8258 0.2296 0.0267 0.0210 4.3960 108.00
Prometheus Biosciences, Inc. RXDX 199.92 0.18 0.09% 1,787 vs. 1,217 9,558.00 1.00 -40.00 -40.00 -371.00 -0.8600 -31.1524 0.0000 1.0000 -36.9919 -0.0586 -0.0539 36.9012 47.00
Arrowhead Pharmaceuticals, Inc. ARWR 21.89 0.50 2.34% 978 vs. 1,052 2,721.00 0.00 -125.00 -126.00 -1,284.00 -1.0200 -6.9465 0.0000 0.0000 0.0000 -0.2590 -0.1312 8.0263 124.00
Krystal Biotech, Inc. KRYS 199.61 14.16 7.64% 400 vs. 209 5,734.00 45.00 0.00 14.00 -268.00 0.0300 1336.3467 0.0000 0.9465 0.0206 0.0012 0.0011 12.2870 28.00
Reata Pharmaceuticals, Inc. RETA 172.36 0.04 0.02% 1,909 vs. 954 6,566.00 22.00 192.00 -70.00 -1,490.00 5.1200 5.4820 0.0000 0.9628 8.4849 2.2110 0.3840 2.8209 38.00
Novo Nordisk A/S NVO 107.20 -0.43 -0.40% 5,217 vs. 4,207 475,026.00 65,349.00 25,407.00 5,305.00 99,050.00 5.7000 38.8598 0.0072 0.8483 0.3888 0.2569 0.0850 0.4372 4,431.00
BioMarin Pharmaceutical Inc. BMRN 67.07 0.13 0.19% 942 vs. 1,768 12,782.00 648.00 88.00 12.00 -532.00 0.4700 46.3847 0.0000 0.7850 0.1366 0.0175 0.0129 1.5477 190.00
Ultragenyx Pharmaceutical Inc. RARE 50.36 -0.07 -0.14% 1,230 vs. 686 4,641.00 108.00 -170.00 -203.00 -3,558.00 -2.0300 -5.7986 0.0000 0.7576 -1.5683 -1.2169 -0.1306 2.1127 92.00
Sarepta Therapeutics, Inc. SRPT 121.61 1.19 0.99% 1,432 vs. 876 11,597.00 413.00 36.00 -284.00 -4,410.00 0.3800 83.5325 0.0000 0.8777 0.0874 0.0376 0.0112 2.9737 95.00
PTC Therapeutics, Inc. PTCT 44.28 1.32 3.07% 996 vs. 668 3,406.00 210.00 -91.00 6.00 -3,375.00 -1.2000 -5.9705 0.0000 0.6846 -0.4358 0.1024 -0.0512 1.8854 76.00
Ionis Pharmaceuticals, Inc. IONS 39.19 0.73 1.90% 987 vs. 1,543 6,180.00 119.00 -142.00 -155.00 -1,938.00 -0.9800 -11.1954 0.0000 0.9347 -1.1950 -0.4816 -0.0517 6.7492 157.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for REGN and its peers to uncover potential buy and sell opportunities.